The Biotech & Life Sciences Project Landscape

Every program below runs on the same mechanics — subproject hierarchy, three resource types, dependency links, milestones, baselines — but the constraint that actually threatens the finish date is different each time.

Project Type Real Constraint How Maverick Models It
Gene & Cell Therapy R&D Custom gRNA/donor template synthesis lead times, an off-target safety QC gate, and a fixed biological observation window (e.g. xenograft engraftment) Material resources for reagents, a Finish-to-Start link gating the QC milestone, critical path through the fixed-duration biological task — the pattern behind the gene therapy blueprint below
Biologics & Antibody Process Development Upstream (cell line, bioreactor) and downstream (purification, formulation) stages run as parallel workstreams that must re-converge before fill-finish Subproject hierarchy holds upstream and downstream as sibling phases, joined by a Finish-to-Finish link at the convergence point
Vaccine Development Programs Antigen design, adjuvant formulation, and stability testing each have independent vendor lead times that rarely land on the same week Each workstream tracked as material resources with independent durations, so a slipped stability-testing shipment is visible without stalling antigen design tasks
Preclinical Toxicology & IND-Enabling Studies GLP study conduct is calendar-driven by animal facility availability, not by staff headcount, and a pre-IND regulatory package has its own internal review chain Human resources model reviewer and study-director roles separately from the animal-facility milestone dates, so a review-chain delay and a facility-calendar delay show up as distinct causes
Clinical Trial Material (CTM) Manufacturing A GMP tech transfer from R&D scale must pass a batch-record and QA sign-off before the first clinical lot can be released A zero-duration milestone marks QA release as a go/no-go gate, with baseline tracking to document any variance for the batch record
In Vitro Diagnostic (IVD) Assay Development Analytical validation (sensitivity, specificity, reproducibility) runs as repeated instrument-bound testing cycles ahead of a submission deadline Machine resources for shared lab instruments surface double-booking across validation runs before it costs a testing cycle

Wet-Lab Resources Are Not a Generic Task List

A research staff member, a shared instrument, and a reagent lot behave completely differently on a schedule — Maverick treats them as three distinct resource types instead of flattening them into one.

Human, machine, and material resource types assigned alongside Gantt chart tasks

Three Resource Types, One Task List

A principal investigator, a bioinformatics scientist, and a study director are Human resources. A thermal cycler, a flow cytometer, and a next-gen sequencer are Machine resources, shared across many tasks in short bursts rather than owned by one study. A gRNA lot, a donor DNA template, and a cell line stock are Material resources with quantities and vendor lead times. All three can be assigned to the same task and checked for conflicts on the same chart.

  • Force-create staff, equipment, and reagents from a single paste
  • Nested workgroups separate Research Staff, Lab Equipment, and Reagents
  • Human resources consume license seats; Machine and Material do not
See resource types
Resource allocation bar chart flagging over-allocated and under-allocated resources

Catch a Shared-Instrument Conflict Before It Costs a Run

A single-point resource — the only qualified flow cytometry operator, or the one animal facility veterinarian on staff — can span weeks of a study across quarantine, monitoring, and terminal analysis. The resource allocation bar chart flags an overlapping double-booking in red before it turns into a missed sampling window, rather than after.

  • Color-coded bars flag over- and under-allocated staff and instruments
  • Filter by workgroup to check one core facility at a time
  • Surfaces a conflict before the baseline is locked, not after
See the allocation chart
Gantt chart with critical path tasks highlighted in red and dependency link lines visible

A Critical Path Through a Sequencer, Not a Crane

Recalculating the critical path on a research program often surfaces a chain running through NGS turnaround time and a fixed biological monitoring window — not a construction task. That distinction matters: a procurement lead time can sometimes be crashed with an expedited order, but a fixed observation period set by biology cannot be shortened by adding staff or working overtime.

  • Four dependency link types model QC gates and study sequencing
  • Instant recalculation as a committee review or assay run slips
  • Separates a compressible lead time from a fixed biological window
Learn about critical path

Why a Generic Task Board Falls Short in a Regulated Lab

Kanban boards and sprint trackers are built for software tickets, not reagent lead times and committee review calendars.

What a Study Needs Generic Task Board Maverick
Reagents and instruments as scheduled resources, not just task labelsNot available — a card can be "assigned" to a person, not tracked as inventory with a lead timeMaterial and Machine resource types with quantities, costs, and vendor lead times
A go/no-go safety or QC gate that blocks downstream work until it passesNot available — columns move forward on manual drag, with no dependency enforcementFinish-to-Start dependency links gate downstream phases behind a milestone
A locked baseline to document schedule variance for a batch record or auditNot available — most boards have no concept of a historical plan to compare againstProject baselines lock the plan and track every later variance
Nested workgroups separating research staff, core facilities, and reagent stockLimited — usually one flat team, not a resource hierarchyUnlimited nested workgroups with per-resource type
License cost that scales with paid staff seats, not every reagent lot loggedVaries by vendor — often per active user regardless of roleOnly Human resources consume a paid seat; Machine and Material do not

Proof: A Real Preclinical R&D Schedule

One worked example, pasted into Maverick as a single tagged text block.

HBB Locus Correction Program — CRISPR-Cas9 Gene Therapy R&D

164 tasks across nine phases and eighteen nested sub-groups, 37 force-created resources split across Human, Machine, and Material types under three workgroups, a Finish-to-Start link gating clonal expansion behind an off-target safety QC review, and a critical path that runs through NGS turnaround and an 84-day xenograft engraftment window — not a construction task.

Walk Through the Blueprint

Report Study Status Without a Maverick Login

Study directors, QA, and program sponsors usually want status outside the scheduling tool itself.

Power BI Dashboards

Build schedule health, timeline, and resource utilization dashboards from live project data, so a program sponsor or QA reviewer can check study status without logging into Maverick.

See the Power BI dashboards

Live OData Feed

Pull projects, tasks, resources, and costs directly into Power BI, Excel, or any OData v4 client via the built-in feed — all 11 entity sets documented with ready-to-paste M queries.

See the OData schema reference

Common Questions From Biotech & Life Sciences Teams

What research operations and study teams ask before switching their scheduling.

Yes. Human, machine, and material resource types let a principal investigator, a flow cytometer, and a lot of custom-synthesized gRNA all be assigned to the same task and checked for scheduling conflicts on one resource-centric Gantt chart.
Yes. Committee review periods are scheduled as ordinary durations with their own resource assignment, and zero-duration milestones mark protocol approval, so a 14-to-21-day review window shows up on the Gantt chart the same way a permit or inspection would on a construction schedule.
Yes. A Finish-to-Start link can gate a downstream phase behind a go/no-go milestone, such as an off-target safety analysis or a genomic stability sign-off, so nothing proceeds until the check passes and a failure is visible on the Gantt chart rather than buried in a lab notebook.
Yes. Both appear as task durations feeding the critical path calculation, but they behave differently in practice: a custom reagent synthesis lead time can sometimes be shortened by an expedited order, while a fixed biological window, such as an engraftment monitoring period, cannot be compressed by adding staff.
Only for Human resources. A principal investigator or lab technician consumes a paid seat, while lab equipment and reagents created as Machine or Material resources do not, which matters when planning license counts for a large research program with many named staff roles.
Yes. A project baseline can be locked before study work begins, and every later variance is tracked against it, which is the same documentation pattern regulatory-facing teams already use for permit and inspection compliance in other industries.

Schedule Your Next Biotech Program

No credit card required. See how Maverick handles wet-lab resources, QC gates, and regulatory milestones in a free trial.